These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 20422041

  • 1. Immunoregulatory actions of epithelial cell PPAR gamma at the colonic mucosa of mice with experimental inflammatory bowel disease.
    Mohapatra SK, Guri AJ, Climent M, Vives C, Carbo A, Horne WT, Hontecillas R, Bassaganya-Riera J.
    PLoS One; 2010 Apr 20; 5(4):e10215. PubMed ID: 20422041
    [Abstract] [Full Text] [Related]

  • 2. The role of T cell PPAR gamma in mice with experimental inflammatory bowel disease.
    Guri AJ, Mohapatra SK, Horne WT, Hontecillas R, Bassaganya-Riera J.
    BMC Gastroenterol; 2010 Jun 10; 10():60. PubMed ID: 20537136
    [Abstract] [Full Text] [Related]

  • 3. Expression of PPAR γ in intestinal epithelial cells is dispensable for the prevention of colitis by dietary abscisic acid.
    Hontecillas R, Bassaganya-Riera J.
    ESPEN J; 2012 Oct 01; 7(5):e189-e195. PubMed ID: 23814701
    [Abstract] [Full Text] [Related]

  • 4. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G.
    Dan Med J; 2015 Jan 01; 62(1):B4973. PubMed ID: 25557335
    [Abstract] [Full Text] [Related]

  • 5. The acetylome regulators Hdac1 and Hdac2 differently modulate intestinal epithelial cell dependent homeostatic responses in experimental colitis.
    Turgeon N, Gagné JM, Blais M, Gendron FP, Boudreau F, Asselin C.
    Am J Physiol Gastrointest Liver Physiol; 2014 Apr 01; 306(7):G594-605. PubMed ID: 24525021
    [Abstract] [Full Text] [Related]

  • 6. Immunoregulatory mechanisms of macrophage PPAR-γ in mice with experimental inflammatory bowel disease.
    Hontecillas R, Horne WT, Climent M, Guri AJ, Evans C, Zhang Y, Sobral BW, Bassaganya-Riera J.
    Mucosal Immunol; 2011 May 01; 4(3):304-13. PubMed ID: 21068720
    [Abstract] [Full Text] [Related]

  • 7. Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease.
    Adachi M, Kurotani R, Morimura K, Shah Y, Sanford M, Madison BB, Gumucio DL, Marin HE, Peters JM, Young HA, Gonzalez FJ.
    Gut; 2006 Aug 01; 55(8):1104-13. PubMed ID: 16547072
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBD.
    Bassaganya-Riera J, Hontecillas R.
    Clin Nutr; 2006 Jun 01; 25(3):454-65. PubMed ID: 16698153
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. T cell PPARγ is required for the anti-inflammatory efficacy of abscisic acid against experimental IBD.
    Guri AJ, Evans NP, Hontecillas R, Bassaganya-Riera J.
    J Nutr Biochem; 2011 Sep 01; 22(9):812-9. PubMed ID: 21109419
    [Abstract] [Full Text] [Related]

  • 15. Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitis.
    Bassaganya-Riera J, Viladomiu M, Pedragosa M, De Simone C, Carbo A, Shaykhutdinov R, Jobin C, Arthur JC, Corl BA, Vogel H, Storr M, Hontecillas R.
    PLoS One; 2012 Sep 01; 7(2):e31238. PubMed ID: 22363592
    [Abstract] [Full Text] [Related]

  • 16. Posttranslational inhibition of proinflammatory chemokine secretion in intestinal epithelial cells: implications for specific IBD indications.
    Hörmannsperger G, Clavel T, Hoffmann M, Reiff C, Kelly D, Loh G, Blaut M, Hölzlwimmer G, Haller D.
    J Clin Gastroenterol; 2010 Sep 01; 44 Suppl 1():S10-5. PubMed ID: 20562631
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. NLRX1 Modulates Immunometabolic Mechanisms Controlling the Host-Gut Microbiota Interactions during Inflammatory Bowel Disease.
    Leber A, Hontecillas R, Tubau-Juni N, Zoccoli-Rodriguez V, Abedi V, Bassaganya-Riera J.
    Front Immunol; 2018 Sep 01; 9():363. PubMed ID: 29535731
    [Abstract] [Full Text] [Related]

  • 19. SCFAs induce autophagy in intestinal epithelial cells and relieve colitis by stabilizing HIF-1α.
    Zhou C, Li L, Li T, Sun L, Yin J, Guan H, Wang L, Zhu H, Xu P, Fan X, Sheng B, Xiao W, Qiu Y, Yang H.
    J Mol Med (Berl); 2020 Aug 01; 98(8):1189-1202. PubMed ID: 32696223
    [Abstract] [Full Text] [Related]

  • 20. Musculin Deficiency Aggravates Colonic Injury and Inflammation in Mice with Inflammatory Bowel Disease.
    Yu J, Liu Y, Zhang W, Yang X, Tang W, Liang H, Li S, Gao W, Yan J.
    Inflammation; 2020 Aug 01; 43(4):1455-1463. PubMed ID: 32239394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.